"Thrombosis"

Compression stockings as thrombosis prophylaxis after abdominal or pelvic surgery Compression stockings as thrombosis prophylaxis after abdominal or pelvic surgery Hoppa till textinnehållet Swedish Agency for Health Technology Assessment and Assessment of Social Services * Other languages * Contact * På svenska * Listen * Publications * Method * Evidence gaps * About SBU Menu Search healthcare system * Our publication types * Core outcome sets COS * Scientific articles published by SBUVisa undermeny * CollaborationVisa undermeny * Other languages * Contact * På svenska * Listen 1. Start 2. Publications 3. Responses from the SBU Enquiry Service 4. Compression stockings as thrombosis prophylaxis after abdominal or pelvic surgery Compression stockings as thrombosis prophylaxis after

Superficial vein thrombosis (superficial thrombophlebitis) - Scenario: Management of superficial vein thrombosis Scenario: Management of superficial vein thrombosis | Management | Superficial vein thrombosis (superficial thrombophlebitis) | CKS | NICE * Skip to content * Accessibility help Search CKS…Skip to contentMenu * Guidance * Standards and indicators * Life sciences * British National Formulary (BNF) * British National Formulary for Children (BNFC) * Clinical Knowledge Summaries (CKS) * * Health topics A to Z * Specialities * What's new * About CKS * About 1. NICE 2. CKS 3. Health topics A to Z 4. Superficial vein thrombosis (superficial thrombophlebitis) 5. Management 6. Scenario: Management of superficial vein thrombosis Superficial vein thrombosis (superficial thrombophlebitis

Deep vein thrombosis Skip to main contentSkip to searchEnglish (US)EnglishPortuguês中文Log in#{autosuggest.search}#{autosuggest.search}HomeDeep vein thrombosis MENULog in or subscribe to access all of BMJ Best PracticeLast reviewed:28 Jan 2024Last updated:22 Feb 2024SummaryDeep vein thrombosis (DVT) is the development of a blood clot within a vein deep to the muscular tissue planes.Patients who that includes DVT and PE. Superficial vein thrombophlebitis (also known as superficial vein thrombosis), a common related condition, affects veins superficial to the musculature. This topic focuses on the diagnosis and management of lower-extremity DVT.History and examKey diagnostic factorscalf swellinglocalised pain along deep venous systempresence of risk factorspositive Wells scoreFull detailsOther

Superficial vein thrombosis Skip to main contentSkip to searchEnglish (US)EnglishPortuguês中文Log in#{autosuggest.search}#{autosuggest.search}HomeSuperficial vein thrombosisVer contenido en español MENULog in or subscribe to access all of BMJ Best PracticeLast reviewed:13 Feb 2024Last updated:08 Mar 2024SummarySuperficial vein thrombosis (SVT, also known as superficial vein thrombophlebitis ) of the lower limb is most often a complication of varicose veins.Doppler (duplex) ultrasonography is recommended for all patients with suspected SVT of the lower limb, as concomitant deep vein thrombosis (DVT) may be present.Underlying prothrombotic conditions should be sought in cases of recurrent SVT and migratory SVT, especially in the absence of varicose veins.Anticoagulation for 45 days to prevent

Anticoagulation in adult patients supported with extracorporeal membrane oxygenation: guidance from the Scientific and Standardization Committees on Perioperative and Critical Care Haemostasis and Thrombosis of the International Society on Thrombosis and Skip to Main ContentLog inISTH SSC COMMUNICATION| VOLUME 21, ISSUE 2, P373-396, FEBRUARY 2023Anticoagulation in adult patients supported with extracorporeal membrane oxygenation: guidance from the Scientific and Standardization Committees on Perioperative and Critical Care Haemostasis and Thrombosis of the International Society on Thrombosis and HaemostasisJulie HelmsCorinne FrereThomas ThieleMarie E. SteinerJean M. ConnorsJerrold H. LevyShow all authorsPublished:December 20, 2022DOI:https://doi.org/10.1016/j.jtha.2022.11.014PlumX

Short-term interruption of treatment with a xaban or dabigatran: sometimes fatal thrombosis Prescrire IN ENGLISH - Spotlight ''Short-term interruption of treatment with a xaban or dabigatran: sometimes fatal thrombosis'', 1 October 2024 {1}##LOC[OK]## {1} ##LOC[OK]## ##LOC[Cancel]## {1}##LOC[OK]####LOC[Cancel]## Register online| Log in| My Prescrire Issue contents * Current issue * Last 12 issues * Subscribe or renew my subscription * Solidarity Subscription Rate * Subscribers: register online * Prescrire's other products * Free Special Edition * Sign up to receive the newsletter english.prescrire.org > Spotlight > 100 most recent > Short-term interruption of treatment with a xaban or dabigatran: sometimes fatal thrombosis SpotlightEvery month, the subjects in Prescrire’s Spotlight. 100 most recent

Hormonal contraception + NSAIDs: deep vein thrombosis and pulmonary embolism Prescrire IN ENGLISH - Spotlight ''Hormonal contraception + NSAIDs: deep vein thrombosis and pulmonary embolism'', 1 November 2024 {1}##LOC[OK]## {1} ##LOC[OK]## ##LOC[Cancel]## {1}##LOC[OK]####LOC[Cancel]## Register online| Log in| My Prescrire Issue contents * Current issue * Last 12 issues * All issues Topics * Annual * Solidarity Subscription Rate * Subscribers: register online * Prescrire's other products * Free Special Edition * Sign up to receive the newsletter english.prescrire.org > Spotlight > 100 most recent > Hormonal contraception + NSAIDs: deep vein thrombosis and pulmonary embolism SpotlightEvery month, the subjects in Prescrire’s Spotlight. 100 most recent: 1|10|20|30|40|50|60|70|80|90 Spotlight * 100 most

Air Travel-related Thrombosis 1 of 4Air Travel-related ThrombosisObjective:To summarize the available literature on the risk of venous thromboembolism (VTE) related to air travel andprovide recommendations for preventative measures while traveling long distances. Background:Long-distance travelling by plane increases the risk of VTE, which includes deep vein thrombosis (DVT) orpulmonary embolism (PE); however, the absolute VTE risk from travel is small.The etiology of travel-related thrombosis likely arises from a combination of immobility (blood stasis in theleg veins), hypobaric environment, vessel damage, and dehydration. Known risk factors for travel-associatedVTE include advanced age (>40 years), height (>185 cm or <165 cm), obesity (BMI >30), hormonal therapy,thrombophilia, pregnancy

Cancer and Thrombosis 1 of 7Cancer and ThrombosisObjective:To assist health care professionals in the management of cancer-associated thrombosis (CAT).Background:Low molecular weight heparin (LMWH) and anti-factor Xa direct oral anticoagulants (DOACs), includingapixaban, edoxaban, and rivaroxaban, are recommended for the treatment of CAT. The major barriers forLMWH use are drug cost & breastfeedingUpfront treatment for VTEs with large clot burden (e.g. submassive PE)Management approaches to Deep Vein Thrombosis (DVT) and/or PulmonaryEmbolism (PE) in cancer patients:LMWH:Therapeutic dosing varies depending on the specific LMWH. While only dalteparin has regulatory indicationin Canada for extended treatment of CAT, the other LMWHs have also been used successfully for thisindication. The following

Cerebral Venous Thrombosis 1 of 6Cerebral Venous ThrombosisObjective:To assist health care professionals in the management of cerebral venous thrombosis (CVT).For information related to cerebral venous thrombosis (CVT) in the context of Vaccine-induced ThromboticThrombocytopenia (VITT), please consult Clinical Guide Vaccine-induced Prothrombotic ImmuneThrombocytopenia (VIPIT/VITT).Background:The cerebral venous system is comprised of the dural venous sinuses, deep and cortical cerebral veins,cavernous sinuses, and internal jugular veins. CVT refers to thrombosis affecting any of these sites. CVT israre, with an incidence of approximately 10 per million person-years and accounting for approximately 1%of all strokes.In contrast with pulmonary embolism (PE) and deep vein thrombosis (DVT), CVT

Portal Vein Thrombosis (PVT) 1 of 4Portal Vein Thrombosis (PVT)Objective:To assist healthcare professionals in the management of portal vein thrombosis (PVT).Background:The portal vein is one of the splanchnic veins, formed at the confluence of the superior mesenteric andsplenic veins and carries blood from the gastrointestinal tract to the liver. PVT can occur in the main portalvein , in the left or right portal branches, and/or in the smaller, intrahepatic branches. PVT is an uncommonsite of thrombosis, estimated to occur in 4 per 100,000 individuals. Risk factors include liver cirrhosis,abdominal surgery, abdominal malignancy, thrombophilia, myeloproliferative neoplasms (MPN), hormoneuse, local inflammation (such as pancreatitis), inflammatory bowel disease, or intra-abdominal

Cavernous sinus thrombosis Skip to main contentSkip to searchLog inEnglish#{autosuggest.search}#{autosuggest.search}Cavernous sinus thrombosis MENULog in or subscribe to access all of BMJ Best PracticeLast reviewed:13 Nov 2023Last updated:12 Dec 2023SummaryCavernous sinus thrombosis (CST) is a thrombus formation within the cavernous sinus, which may be either septic or aseptic in origin . Infection can spread to the cavernous sinus either as an extension of thrombophlebitis or by septic emboli. The origin of aseptic cavernous sinus thrombosis is usually through trauma or a prothrombotic condition.In the pre-antibiotic era, infections of the middle third of the face were responsible for the majority of cases. Currently, acute sinusitis is the most common predisposing condition.Diagnosis

COVID-19 rapid guideline: vaccine-induced immune thrombocytopenia and thrombosis (VITT) COVID-19 rapid guideline: vaccine-induced immune thrombocytopenia and thrombosis (VITT) Main editor NICE Publishing, version history and subscription 5.0 published on 22.06.2022 The National Institute for Health and Care Excellence (NICE) logo The National Institute for Health and Care Excellence (NICE) COVID -19 rapid guideline: vaccine-induced immune thrombocytopenia and thrombosis (VITT) Guideline for VITT created 2.6.21 AP Contact COVID-19 rapid guideline: vaccine-induced immune thrombocytopenia and thrombosis (VITT) - The National Institute for Health and Care2 of 41Sections Summary of recommendations

Deep vein thrombosis - When to suspect DVT When to suspect DVT | Diagnosis | Deep vein thrombosis | CKS | NICE * Skip to content * Accessibility help Search CKS…Skip to contentMenu * Guidance * Standards and indicators * Life sciences * British National Formulary (BNF) * British National Formulary for Children (BNFC) * Clinical Knowledge Summaries (CKS) * * Health topics A to Z * Specialities * What's new * About CKS * About 1. NICE 2. CKS 3. Health topics A to Z 4. Deep vein thrombosis 5. Diagnosis 6. When to suspect DVT Deep vein thrombosis: When should I suspect deep vein thrombosis?Last revised in February 2025 When to suspect DVT * Summary * Have I got the right topic? * How up-to-date is this topic? * Goals and outcome measures * Background information * Diagnosis * When to suspect DVT

Deep vein thrombosis - Differential diagnosis Differential diagnosis | Diagnosis | Deep vein thrombosis | CKS | NICE * Skip to content * Accessibility help Search CKS…Skip to contentMenu * Guidance * Standards and indicators * Life sciences * British National Formulary (BNF) * British National Formulary for Children (BNFC) * Clinical Knowledge Summaries (CKS) * * Health topics A to Z * Specialities * What's new * About CKS * About 1. NICE 2. CKS 3. Health topics A to Z 4. Deep vein thrombosis 5. Diagnosis 6. Differential diagnosis Deep vein thrombosis: What are the differential diagnoses of deep vein thrombosis?Last revised in February 2025 Differential diagnosis * Summary * Have I got the right topic? * How up-to-date is this topic? * Goals and outcome measures * Background information

Deep vein thrombosis - Scenario: Management Scenario: Management | Management | Deep vein thrombosis | CKS | NICE * Skip to content * Accessibility help Search CKS…Skip to contentMenu * Guidance * Standards and indicators * Life sciences * British National Formulary (BNF) * British National Formulary for Children (BNFC) * Clinical Knowledge Summaries (CKS) * * Health topics A to Z * Specialities * What's new * About CKS * About 1. NICE 2. CKS 3. Health topics A to Z 4. Deep vein thrombosis 5. Management 6. Scenario: Management Deep vein thrombosis: Scenario: Management of deep vein thrombosisLast revised in February 2025 Covers the management of people with suspected deep vein thrombosis (DVT) and the ongoing management of people with confirmed DVT following initial hospital treatment. Scenario

Deep vein thrombosis - Parenteral anticoagulants Parenteral anticoagulants | Prescribing information | Deep vein thrombosis | CKS | NICE * Skip to content * Accessibility help Search CKS…Skip to contentMenu * Guidance * Standards and indicators * Life sciences * British National Formulary (BNF) * British National Formulary for Children (BNFC) * Clinical Knowledge Summaries (CKS) * * Health topics A to Z * Specialities * What's new * About CKS * About 1. NICE 2. CKS 3. Health topics A to Z 4. Deep vein thrombosis 5. Prescribing information 6. Parenteral anticoagulants Deep vein thrombosis: Parenteral anticoagulantsLast revised in February 2025 Parenteral anticoagulants * Summary * Have I got the right topic? * How up-to-date is this topic? * Goals and outcome measures * Background information

Deep vein thrombosis - Oral anticoagulants Oral anticoagulants | Prescribing information | Deep vein thrombosis | CKS | NICE * Skip to content * Accessibility help Search CKS…Skip to contentMenu * Guidance * Standards and indicators * Life sciences * British National Formulary (BNF) * British National Formulary for Children (BNFC) * Clinical Knowledge Summaries (CKS) * * Health topics A to Z * Specialities * What's new * About CKS * About 1. NICE 2. CKS 3. Health topics A to Z 4. Deep vein thrombosis 5. Prescribing information 6. Oral anticoagulants Deep vein thrombosis: Oral anticoagulantsLast revised in February 2025 Oral anticoagulants * Summary * Have I got the right topic? * How up-to-date is this topic? * Goals and outcome measures * Background information * Diagnosis * Management

Deep vein thrombosis - Definition Definition | Background information | Deep vein thrombosis | CKS | NICE * Skip to content * Accessibility help Search CKS…Skip to contentMenu * Guidance * Standards and indicators * Life sciences * British National Formulary (BNF) * British National Formulary for Children (BNFC) * Clinical Knowledge Summaries (CKS) * * Health topics A to Z * Specialities * What's new * About CKS * About 1. NICE 2. CKS 3. Health topics A to Z 4. Deep vein thrombosis 5. Background information 6. Definition Deep vein thrombosis: What is it?Last revised in February 2025 Definition * Summary * Have I got the right topic? * How up-to-date is this topic? * Goals and outcome measures * Background information * Definition * Incidence * Risk factors * Complications * Diagnosis

Deep vein thrombosis - Incidence Incidence | Background information | Deep vein thrombosis | CKS | NICE * Skip to content * Accessibility help Search CKS…Skip to contentMenu * Guidance * Standards and indicators * Life sciences * British National Formulary (BNF) * British National Formulary for Children (BNFC) * Clinical Knowledge Summaries (CKS) * * Health topics A to Z * Specialities * What's new * About CKS * About 1. NICE 2. CKS 3. Health topics A to Z 4. Deep vein thrombosis 5. Background information 6. Incidence Deep vein thrombosis: How common is it?Last revised in February 2025 Incidence * Summary * Have I got the right topic? * How up-to-date is this topic? * Goals and outcome measures * Background information * Definition * Incidence * Risk factors * Complications * Diagnosis